PWPCM
GILD icon

Perella Weinberg Partners Capital Management’s Gilead Sciences GILD Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,000
Closed -$981K – 68
2015
Q1 		$981K Buy
+10,000
New +$1.02M 0.93% 34
2014
Q2 		– Sell
-188,000
Closed -$13.3M – 143
2014
Q1 		$13.3M Buy
+188,000
New +$14.7M 1.76% 12

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Perella Weinberg Partners Capital Management's GILD Position: Q1 2019 in Review

Perella Weinberg Partners Capital Management sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 12,674 shares — an estimated $793K sold.

Perella Weinberg Partners Capital Management first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $10.6M in Q2 2013. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Perella Weinberg Partners Capital Management reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Perella Weinberg Partners Capital Management sold 12,674 Gilead Sciences shares in Q1 2019, an estimated $793K.
  • Perella Weinberg Partners Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
  • Perella Weinberg Partners Capital Management's Gilead Sciences position peaked at $10.6M in Q2 2013.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q1 2019, filed 6 May 2019.